Back to today’s briefing

Story perspectives

Clonazepam's 52,000 km Journey Sparks Sustainability Debate

5/27/2025

40 4

Summary

Story summary

A recent study in the Canadian Family Physician journal uncovers the astonishing journey of clonazepam, an anxiety medication, which travels over 52,000 kilometers across various countries before reaching Canadian patients. This intricate supply chain, heavily reliant on China and India, faces disruptions and significantly impacts greenhouse gas emissions, sparking urgent demands for a more sustainable and resilient system.

1 of 1

Story summary

A recent study in the Canadian Family Physician journal uncovers the astonishing journey of clonazepam, an anxiety medication, which travels over 52,000 kilometers across various countries before reaching Canadian patients. This intricate supply chain, heavily reliant on China and India, faces disruptions and significantly impacts greenhouse gas emissions, sparking urgent demands for a more sustainable and resilient system.